Primary Glomerulonephritis with Isolated C3 Deposits: a New Entity Which Shares Common Genetic Risk Factors with Haemolytic Uraemic Syndrome

Overview

Journal J Med Genet

Specialty Genetics

Date 2006 Oct 5

PMID 17018561

Citations 121

Authors

Aude Servais

Veronique Fremeaux-Bacchi

Moglie Lequintrec

Remi Salomon

Jacques Blouin

Bertrand Knebelmann

Jean-Pierre Grunfeld

Philippe Lesavre

Laure-Helene Noel

Fadi Fakhouri

Affiliations

Soon will be listed here.

Abstract

Introduction: Abnormal control of the complement alternative pathway (CAP) (factor H, factor I and membrane cofactor protein (MCP) deficiencies) is a well established risk factor for the occurrence of haemolytic uraemic syndrome (HUS). In some instances, HUS may be associated with an unusual glomerulonephritis with isolated C3 deposits (glomerulonephritis C3). We determined whether HUS and glomerulonephritis C3 share common genetic susceptibility factors.

Methods: We identified 19 patients with glomerulonephritis C3. We measured levels of circulating complement components, performed assays for the detection of C3 nephritic factor (C3NeF) and screened factor H, factor I and MCP coding genes for the presence of mutations.

Results: Patients were divided in two groups based on renal pathology findings: group I (n = 13) had typical features of type I membranoproliferative glomerulonephritis (glomerulonephritis C3 with membranoproliferative glomerulonephritis (MPGN)) and group II (n = 6) was characterised by mesangial and epimembranous C3 deposits in the absence of mesangial proliferation (glomerulonephritis C3 without MPGN). Mutations in complement regulatory genes were detected in 4/6 patients with glomerulonephritis C3 without MPGN (heterozygous mutations in factor H gene (two patients) with low factor H antigenic level in one case, heterozygous mutations in factor I gene (two patients)) and in only 2/13 patients with glomerulonephritis C3 with MPGN (heterozygous mutations in factor H gene (one patient) and double heterozygous mutation in CD 46 gene (one patient)). In contrast, C3NeF was present in 5/13 patients with glomerulonephritis C3 with MPGN and in 2/6 patients with glomerulonephritis C3 without MPGN, one of whom had a factor H mutation.

Conclusion: HUS and glomerulonephritis C3 without MPGN share common genetic risk factors. Constitutional or acquired dysregulation of the CAP is probably associated with a wide spectrum of diseases, ranging from HUS to glomerulonephritis C3 with MPGN.

Citing Articles

Anticomplement Therapies for C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis Recurrence - A Dawn of New Hope.

Emma F, John P Kidney Int Rep. 2025; 10(1):7-9.

PMID: 39812304 PMC: 11725961. DOI: 10.1016/j.ekir.2024.11.018.

C3 glomerulopathy in children: a European longitudinal study evaluating outcome.

Cappoli A, Kersnik-Levart T, Silecchia V, Ariceta G, Gjerstad A, Ghiggeri G Pediatr Nephrol. 2024; 40(4):979-986.

PMID: 39589481 DOI: 10.1007/s00467-024-06587-z.

C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis.

Ponticelli C, Calatroni M, Moroni G Front Med (Lausanne). 2023; 10:1289812.

PMID: 38076230 PMC: 10704907. DOI: 10.3389/fmed.2023.1289812.

The role of complement in kidney disease.

Petr V, Thurman J Nat Rev Nephrol. 2023; 19(12):771-787.

PMID: 37735215 DOI: 10.1038/s41581-023-00766-1.

[Diagnosis and treatment of glomerular diseases with a membranoproliferative glomerulonephritis (MPGN) pattern of injury].

Rudnicki M, Windpessl M, Eller K, Odler B, Gauckler P, Neumann I Wien Klin Wochenschr. 2023; 135(Suppl 5):688-695.

PMID: 37728653 PMC: 10511362. DOI: 10.1007/s00508-023-02264-7.

References

Hamburger J, CROSNIER J, Noel L . Recurrent glomerulonephritis after renal transplantation. Annu Rev Med. 1978; 29:67-72. DOI: 10.1146/annurev.me.29.020178.000435. View

Yoshizawa N, Yamakami K, Fujino M, Oda T, Tamura K, Matsumoto K . Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol. 2004; 15(7):1785-93. DOI: 10.1097/01.asn.0000130624.94920.6b. View

Levy M, Halbwachs-Mecarelli L, Gubler M, Kohout G, Bensenouci A, Niaudet P . H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int. 1986; 30(6):949-56. DOI: 10.1038/ki.1986.278. View

Fremeaux-Bacchi V, WEISS L, Demouchy C, May A, Palomera S, Kazatchkine M . Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity. Nephrol Dial Transplant. 1994; 9(12):1747-50. View

Warwicker P, Goodship T, Donne R, Pirson Y, Nicholls A, Ward R . Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int. 1998; 53(4):836-44. DOI: 10.1111/j.1523-1755.1998.00824.x. View

Cu G, Mezzano S, Bannan J, Zabriskie J . Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int. 1998; 54(3):819-26. DOI: 10.1046/j.1523-1755.1998.00052.x. View

Liszewski M, Leung M, Atkinson J . Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. J Immunol. 1998; 161(7):3711-8. View

Jha V, Murthy M, Kohli H, Sud K, Gupta K, Joshi K . Secondary membranoproliferative glomerulonephritis due to hemolytic uremic syndrome: an unusual presentation. Ren Fail. 1998; 20(6):845-50. DOI: 10.3109/08860229809045182. View

Dragon-Durey M, Loirat C, Cloarec S, Macher M, Blouin J, Nivet H . Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2004; 16(2):555-63. DOI: 10.1681/ASN.2004050380. View

10.

Appel G, Cook H, Hageman G, Jennette J, Kashgarian M, Kirschfink M . Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol. 2005; 16(5):1392-403. DOI: 10.1681/ASN.2005010078. View

11.

Kavanagh D, Kemp E, Mayland E, Winney R, Duffield J, Warwick G . Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2005; 16(7):2150-5. DOI: 10.1681/ASN.2005010103. View

12.

Genel F, Sjoholm A, Skattum L, Truedsson L . Complement factor I deficiency associated with recurrent infections, vasculitis and immune complex glomerulonephritis. Scand J Infect Dis. 2005; 37(8):615-618. DOI: 10.1080/00365540510034536. View

13.

Jozsi M, Heinen S, Hartmann A, Ostrowicz C, Halbich S, Richter H . Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions. J Am Soc Nephrol. 2005; 17(1):170-7. DOI: 10.1681/ASN.2005080868. View

14.

Pickering M, Warren J, Rose K, Carlucci F, Wang Y, Walport M . Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A. 2006; 103(25):9649-54. PMC: 1476693. DOI: 10.1073/pnas.0601094103. View

15.

Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P . Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006; 108(4):1267-79. PMC: 1895874. DOI: 10.1182/blood-2005-10-007252. View

16.

Richards A, Liszewski M, Kavanagh D, Fang C, Moulton E, Fremeaux-Bacchi V . Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Mol Immunol. 2006; 44(1-3):111-22. DOI: 10.1016/j.molimm.2006.07.004. View

17.

Batsford S, Mezzano S, Mihatsch M, Schiltz E, Rodriguez-Iturbe B . Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?. Kidney Int. 2005; 68(3):1120-9. DOI: 10.1111/j.1523-1755.2005.00504.x. View

18.

Gonzalez-Rubio C, Gallardo M, Vera M, Lopez-Trascasa M, Rodriguez de Cordoba S, Sanchez-Corral P . Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet. 2001; 68(2):478-84. PMC: 1235280. DOI: 10.1086/318201. View

19.

Caprioli J, Bettinaglio P, Zipfel P, Amadei B, Daina E, Gamba S . The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol. 2001; 12(2):297-307. DOI: 10.1681/ASN.V122297. View

20.

Schwertz R, Rother U, Anders D, Gretz N, Scharer K, Kirschfink M . Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up. Pediatr Allergy Immunol. 2001; 12(3):166-72. DOI: 10.1034/j.1399-3038.2001.012003166.x. View